REMUS — Remus Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for Remus Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	11.5	30.4	293	246	549
Net Total Accounts Receivable
Net Total Receivables	49.6	80.2	1,375	1,412	1,495
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	76.9	113	2,097	2,214	2,946
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3.08	25.1	22.8	68.3	178
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	159	347	2,573	4,326	5,787
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	92	81.6	1,495	1,215	1,491
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	94.8	155	1,704	1,768	2,277
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	64.3	191	869	2,559	3,510
Total Liabilities & Shareholders' Equity	159	347	2,573	4,326	5,787
Total Common Shares Outstanding